2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone has been researched along with nsc 95397 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahn, YJ; Jeong, DG; Jung, SK; Kim, SJ; Lee, SH; Park, H; Ryu, SE; Seo, I; Yoon, TS | 1 |
| Danilenko, NV; Karpenko, AS; Khlebnikov, AI; Kirpotina, LN; Levandovskiy, IA; Quinn, MT; Schepetkin, IA; Shibinska, MO | 1 |
2 other study(ies) available for 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and nsc 95397
| Article | Year |
|---|---|
Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
Topics: Amino Acid Sequence; Catalytic Domain; cdc25 Phosphatases; Crystallography, X-Ray; Drug Evaluation, Preclinical; Enzyme Inhibitors; Models, Molecular; Molecular Sequence Data; Sequence Homology, Amino Acid; Structure-Activity Relationship | 2008 |
Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
Topics: Antineoplastic Agents; cdc25 Phosphatases; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Humans; MAP Kinase Kinase 7; Models, Molecular; Molecular Docking Simulation; Naphthoquinones | 2019 |